Drug Profile
Research programme: anti-fibrotic agents - Pfizer
Alternative Names: UK-383,367; UK-421,045Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class Hydroxamic acids; Oxadiazoles; Sulfonamides
- Mechanism of Action Bone morphogenetic protein receptor type I antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Scars